merck glp 1 drug The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity GLP-1 receptor agonists and next-generation

Nicotinic acetylcholine receptor subtype alpha-9 mediates triple-negative breast cancers based on a spontaneous pulmonary metastasis mouse model

Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache

Ipamorelin shares the hypothalamic effects common to GHRPs somatostatin suppression and GHRH neuron stimulation which contribute to its utility in combination protocols

In our earlier GLP-1 Insight Drop, we showed how the 2021 approval of Wegovy catalyzed a step-change in metabolic R&Dso much so that GLP-1 programs now account for 159 out of 426 active metabolic programs (~40%), effectively lifting the entire category